CYBERMED LIFE - ORGANIC  & NATURAL LIVING

Laser Treatment - Low-Level

Effects of low-level laser therapy on pain in patients with musculoskeletal disorders. A systemic review and meta-analysis. 📎

Written by CYBERMED LIFE NEWS
Attachments:
Download this file (Effects of low-level laser therapy on pain in patients with musculoskeletal disorders - a systematic review and meta-analysis..pdf)Effects of low-level laser therapy on pain in patients with musculoskeletal disorders - a systematic review and meta-analysis..pdf[Effects of low-level laser therapy on pain in patients with musculoskeletal disorders: a systematic review and meta-analysis.]599 kB
facebook Share on Facebook
Abstract Title:

Effects of low-level laser therapy on pain in patients with musculoskeletal disorders. A systemic review and meta-analysis.

Abstract Source:

Eur J Phys Rehabil Med. 2017 Jan 30. Epub 2017 Jan 30. PMID: 28145397

Abstract Author(s):

Ron Clijsen, Anina Brunner, Marco Barbero, Peter Clarys, Jan Taeymans

Article Affiliation:

Ron Clijsen

Abstract:

INTRODUCTION: This meta-analysis investigated the effectiveness of low-level laser therapy (LLLT) on pain in adult patients with musculoskeletal disorders.

EVIDENCE ACQUISITION: A systematic literature search was conducted in the Medline and PEDro databases. Two researchers independently screened titles and abstracts of the retrieved studies for eligibility. Quality assessment of the eligible studies was conducted using the PEDro rating scale. Studies that scored≥ 4 were included. A random-effects model was used for this meta-analysis. Subgroup meta-analyses were conducted to evaluate the influence of the adherence of the applied LLLT to the World Association of Laser Therapy (WALT) guidelines, the anatomical site under investigation and the study designon the overall weighted mean effect size. Meta regression was used to assess the possible influence of the study quality on the individual study effect sizes.

EVIDENCE SYNTHESIS: Eighteen studies allowing for 21 head-to-head comparisons (totaling n=1462 participants) were included. The pooled raw mean difference (D) in pain between LLLT and the control groups was -0.85 [95%CI: -1.22 to -0.48]. There was high (I² = 85.6%) and significant between study heterogeneity (Cochran's Q = 139.2; df = 20; p<0.001). The subgroup meta-analysis of the comparisons not following the WALT guidelines revealed a D = -0.68 [95%CI: -1.09 to -0.27]. In this group, heterogeneity decreased to I² = 72.6% (Q = 51.2; df = 14; p<0.001). In the WALT subgroup D equaled -1.52 [95%CI: -2.34 to -0.70]. this between groups difference was clinically relevant although statistically not significant (Q = 3.24; df = 1; p = 0.072).

CONCLUSIONS: This meta-analysis presents evidence that LLLT is an effective treatment modality to reduce pain in adult patients with musculoskeletal disorders. Adherence to WALT dosage recommendations seems to enhance treatment effectiveness.


We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.